Recent

Skandinaviska Enskilda Banken AB (publ) (”SEB” or the “Joint Global Coordinator”) has today notified Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) and the selling shareholders (GLA Invest S A, MCGA AB, h265 AB and Petter Wallin) (the “Selling Shareholders”) that the over-allotment option has been exercised in full and that the stabilisation period has ended.

The number of shares and votes in Sleep Cycle AB (publ) (“Sleep Cycle”) have changed as a result of the issue of shares carried out in connection with the listing of Sleep Cycle’s shares on Nasdaq Stockholm on 8 June 2021.

Sleep Cycle AB (publ) ("Sleep Cycle” or the "Company”), a market leading[1] sleep tracking application with a mission to empower people to sleep better to improve global health, today announces the outcome of the initial public offering of Sleep Cycle’s shares and the listing on Nasdaq Stockholm (the “Offering”). The Offering attracted strong interest from Swedish and international institutional investors and the general public in Sweden. As a result of the Offering, Sleep Cycle will have more than 6,000 shareholders.

Following the announcement of its intention to float on 19 May 2021, Sleep Cycle AB (publ) (”Sleep Cycle” or the ”Company”), a market leading sleep tracking application, today publishes its prospectus and announces the price for the offering (the “Offering”) and listing of its shares on Nasdaq Stockholm. The first day of trading is expected to be 8 June 2021.

Gothenburg, Sweden - May 19, 2021Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”), a market leading sleep tracking application, hereby announces its intention to launch an initial public offering of its shares (the "IPO" or the ”Offering”) and to list its shares on Nasdaq Stockholm. The Offering is expected to consist of existing shares in the Company offered by the Selling Shareholders (as defined below) and newly issued shares.

BOSTON, MA – Feb. 8, 2021 – A study published in the Journal of Medical Internet Research finds that COVID-19 mitigation strategies and changes in our daily routines may have increased global estimated sleep duration by up to 25 minutes. This significant increase in total sleep time is comparable to the impact of hypnotic medication, or common sleep aids, and may be clinically important as sleep deprivation increases susceptibility to viral infection and diminished the immune response to vaccination.

The COVID-19 pandemic has fundamentally changed our lives in nearly every way, impacting the way we work, live, and our ability to sleep. A new report conducted by Sleep Cycle, the world’s most popular intelligent sleep app, suggests these changes have profoundly impacted sleep and mental health on a global scale.

As part of Sleep Cycle 10 year anniversary, Sleep Cycle CEO Carl Johan Hederoth shares his thoughts on the success over the years.